Trial Profile
Efficacy and safety of standard versus low dose solifenacin and trospium in elderly patients with moderate overactive bladder symptoms
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Trospium chloride (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 11 Sep 2015 New trial record